Business Context and Reporting Period
Company: Aptargroup, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2010
Business Overview: Aptargroup operates in the packaging industry, developing, manufacturing, and selling consumer product dispensing systems. The company is organized into three reporting segments: Beauty & Home, Closures, and Pharma.
Key Financial Metrics
| Metric (in thousands, except per share) | Q1 2010 | Q1 2009 |
|---|---|---|
| Net Sales | $505,469 | $431,816 |
| Operating Income | $61,626 | $40,556 |
| Net Income Attributable to Aptargroup | $39,022 | $26,665 |
| Diluted EPS | $0.56 | $0.38 |
| Operating Margin | 12.2% | 9.4% |
| Effective Tax Rate | 32.5% | 30.5% |
| Cash and Equivalents (End of Period) | $337,807 | $203,882 |
| Net Cash Provided by Operations | $30,235 | $48,777 |
| Total Debt (Short & Long Term) | $367,000 | $338,000 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 17% year-over-year. Approximately 6% of this increase was attributed to favorable foreign currency translation (weakening U.S. dollar vs. Euro and Brazilian Real). Organic product and custom tooling sales rose 11%.
- Profitability: Operating income increased 52% to $61.6 million. Operating margin expanded to 12.2% from 9.4%, driven by improved overhead utilization and cost leverage against higher sales volumes.
- Cost Structure: Cost of sales as a percentage of net sales decreased to 65.5% from 67.1%. This improvement was offset by increasing raw material costs (specifically plastic resin) and the negative impact of the weakening U.S. dollar on Euro-denominated costs.
- Cash Flow: Operating cash flow decreased to $30.2 million from $48.8 million, primarily due to increased working capital needs to support business growth.
- Segment Performance:
- Beauty & Home: Sales up 24%; Segment income up 150% to $27.0 million.
- Closures: Sales up 15%; Segment income up 47% to $17.1 million.
- Pharma: Sales up 4%; Segment income up 2% to $29.7 million.
Guidance, Outlook, and Risks
- Outlook: Management anticipates growth in the second quarter of 2010 driven by a recovering economic climate and the absence of the inventory destocking seen in 2009. Demand is expected to remain strong in fragrance/cosmetic and personal care markets.
- Earnings Guidance: Diluted earnings per share for Q2 2010 are expected to be in the range of $0.60 to $0.65, compared to $0.41 in the prior year.
- Capital Allocation: The company repurchased 200,000 shares for $8.0 million in Q1. A quarterly dividend of $0.15 per share was declared. Estimated capital expenditures for 2010 are approximately $125 million.
- Risks and Contingencies:
- Foreign Currency: Significant exposure to the Euro, British Pound, and other currencies; a strengthening U.S. dollar would have a dilutive effect.
- Raw Materials: Volatility in resin, metal, and energy costs.
- ERP Implementation: Risks associated with the successful implementation of a new worldwide enterprise resource planning system.
- Legal: Subject to normal lawsuits and claims; management does not expect a material adverse effect.
Investor Verification Checklist
- Verify the sustainability of the 17% sales growth, distinguishing between organic volume growth and foreign currency translation effects.
- Monitor raw material costs (resin) and the company's ability to pass these costs to customers without impacting demand.
- Review the impact of the weakening U.S. dollar on future earnings if the currency trend reverses.
- Confirm the timeline and cost implications of the global ERP system rollout.
- Assess the company's ability to maintain the projected Q2 2010 EPS range of $0.60–$0.65 given current market conditions.